scispace - formally typeset
M

Marieke D. Spreeuwenberg

Researcher at Public Health Research Institute

Publications -  121
Citations -  5140

Marieke D. Spreeuwenberg is an academic researcher from Public Health Research Institute. The author has contributed to research in topics: Health care & Referral. The author has an hindex of 36, co-authored 117 publications receiving 4563 citations. Previous affiliations of Marieke D. Spreeuwenberg include Maastricht University & VU University Medical Center.

Papers
More filters
Journal ArticleDOI

Upgrading physical activity counselling in primary care in the Netherlands

TL;DR: The systematic development of a counselling protocol in primary care combined with a monitoring and feedback tool to support chronically ill patients to achieve a more active lifestyle has led to a practical and affordable protocol for physical activity counselling combined with mobile technology.
Journal ArticleDOI

Get moving: the practice nurse is watching you!

TL;DR: In this article, a monitoring and feedback system to support patients in their intention to be more active was developed in a systematic way, which consists of an accelerometer that transfers data to a smartphone, which is subsequently connected to a server.
Proceedings Article

Get Moving - the Practice Nurse is Watching You!

TL;DR: In this article, a monitoring and feedback system to support patients in their intention to be more active was developed in a systematic way, which consists of an accelerometer that transfers data to a smartphone, which is subsequently connected to a server.
Journal ArticleDOI

Estimating Subgroup Effects Using the Propensity Score Method A Practical Application in Outcomes Research

TL;DR: The results support the use of the generalized PS as a feasible method, compared with the univariate PS, to find certain subgroup effects in nonrandomized outcomes research.
Journal ArticleDOI

The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients.

TL;DR: In critically ill patients plasma ADMA levels were elevated and associated with the extent of multiple organ failure, but no significant ADMA-lowering effect of the PPAR-gamma agonist rosiglitazone was observed.